Clinical Trial Update: Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating SCH 900435 (Org 25935) for relapse prevention in alcohol dependence has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcoholism

Drugs mentioned

• SCH 900435 (Org 25935) (SCH 900435)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alcoholism | Phase 2 | Status: TERMINATED | Results posted: 2016-09-01